康德莱：控股股东协议转让股份过户完成

Core Viewpoint - Kangdelai's controlling shareholder, Kangdelai Holdings Group, has transferred approximately 21.84 million unrestricted circulating shares (5% of total share capital) at a price of 10.81 yuan per share to Changsha Medical [1] Group 1: Share Transfer Details - The share transfer transaction has received compliance confirmation from the Shanghai Stock Exchange and the transfer registration procedures have been completed [1] - The transfer date was October 21, 2025, and the shares involved are unrestricted circulating shares [1] Group 2: Company Financials - For the year 2024, Kangdelai's revenue composition is as follows: 99.6% from medical device manufacturing and 0.4% from other businesses [1] - As of the report date, Kangdelai's market capitalization is 4 billion yuan [1]